PRESS RELEASE published on 01/15/2026 at 14:05, 4 months 1 day ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2025: Record net sales and significant earnings growth – forecast for 2026 Drägerwerk AG & Co. KGaA reports record net sales and significant earnings growth in 2025, with a forecast for 2026. Medical and safety divisions contribute to the positive results Net Sales Forecast Earnings Growth 2025 Drägerwerk AG
BRIEF published on 11/20/2025 at 11:37, 5 months 27 days ago Drägerwerk finalise le rachat d'actions pour son programme d'actionnariat salarié. Rachat D'actions Conformité Réglementaire Actions Privilégiées Drägerwerk AG Programme D'actionnariat Salarié
BRIEF published on 11/20/2025 at 11:37, 5 months 27 days ago Drägerwerk Completes Share Buyback for Employee Program Share Buyback Regulation Compliance Preferred Shares Drägerwerk AG Employee Stock Program
PRESS RELEASE published on 11/20/2025 at 11:32, 5 months 27 days ago Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice Drägerwerk AG & Co. KGaA completed the share buyback for the annual employee stock program as of November 12, 2025, with a total of 70,000 preferred shares repurchased from June 3 to July 18 Share Buyback Preferred Shares Drägerwerk AG Employee Stock Program Regulation EU No 596/2014
BRIEF published on 10/29/2025 at 07:35, 6 months 19 days ago Drägerwerk AG & Co. KGaA annonce une forte croissance de la demande et des bénéfices en 2025 Croissance Des Ventes Nettes Divisions Médicales Et De Sécurité Drägerwerk AG Prise De Commande Résultats 2025
BRIEF published on 10/29/2025 at 07:35, 6 months 19 days ago Drägerwerk AG & Co. KGaA Reports Strong Demand and Earnings Growth in 2025 Net Sales Growth Order Intake Medical And Safety Divisions Drägerwerk AG 2025 Earnings
PRESS RELEASE published on 10/29/2025 at 07:30, 6 months 19 days ago Drägerwerk AG & Co. KGaA: Dräger with strong demand, noticeable net sales growth and very good earnings performance in the first nine months of 2025 Drägerwerk AG & Co. KGaA reports strong demand, noticeable net sales growth, and very good earnings performance in the first nine months of 2025, with order intake and EBIT up Net Sales Growth Earnings 2025 Drägerwerk AG Demand
BRIEF published on 10/15/2025 at 19:29, 7 months 1 day ago Drägerwerk AG & Co. KGaA annonce de solides résultats pour le troisième trimestre 2025 Croissance Des Ventes Nettes Drägerwerk Augmentation De L'EBIT Divisions Médicales Et De Sécurité Résultats Du Troisième Trimestre 2025
BRIEF published on 10/15/2025 at 19:29, 7 months 1 day ago Drägerwerk AG & Co. KGaA Reports Strong Q3 2025 Results Net Sales Growth Drägerwerk EBIT Increase Medical And Safety Divisions Q3 2025 Earnings
PRESS RELEASE published on 10/15/2025 at 19:24, 7 months 1 day ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2025: Significant increase in net sales and earnings – upper half of forecast range expected Drägerwerk AG & Co. KGaA reports significant increase in Q3 2025 net sales and earnings, exceeding prior year's levels. Forecast for 2025 indicates strong performance in upper range Net Sales Forecast Earnings Drägerwerk Q3 2025
Published on 05/16/2026 at 01:15, 1 day 12 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 13 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 14 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 1 day 14 hours ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 21 hours 49 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 17 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 19 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 22 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 22 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 3 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 4 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days 19 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES